KRAS
Gwedd
Protein sy'n cael ei godio yn y corff dynol gan y genyn KRAS yw KRAS a elwir hefyd yn V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b a KRAS proto-oncogene, GTPase (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn ôl o gromosom dynol 12, band 12p12.1.[2]
Cyfystyron
[golygu | golygu cod]Yn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn KRAS.
- NS
- NS3
- CFC2
- RALD
- K-Ras
- KRAS1
- KRAS2
- RASK2
- KI-RAS
- C-K-RAS
- K-RAS2A
- K-RAS2B
- K-RAS4A
- K-RAS4B
- c-Ki-ras2
Llyfryddiaeth
[golygu | golygu cod]- "Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells. ". Cancer Sci. 2017. PMID 28846180.
- "The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis. ". PLoS One. 2017. PMID 28796802.
- "Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression. ". Anticancer Res. 2017. PMID 29187496.
- "FNA smears of pancreatic ductal adenocarcinoma are superior to formalin-fixed paraffin-embedded tissue as a source of DNA: Comparison of targeted KRAS amplification and genotyping in matched preresection and postresection samples. ". Cancer Cytopathol. 2017. PMID 29024530.
- "Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.". Medicine (Baltimore). 2017. PMID 28858102.